BCR and diffuse large B-cell lymphoma: However, the maximum pyruvate-to-citrate labeling ratio in both OxPhos- and BCR-DLBCL subgroups is low, and labeling of TCA-cycle metabolites downstream of citrate is almost nonexistent.